“West has been at the forefront of pharmaceutical packaging for over 100 years and is the market leader for containment solutions for cell and gene therapy treatments,” said Cindy Reiss ...

West Pharmaceutical shares plummeted 38.2% after reporting Q4 2024 earnings despite surpassing revenue and profit expectations. The sharp decline was driven by disappointing full-year guidance ...

In the past month, West Pharmaceutical Services observed a 13% rise in its share price. Several key developments could help explain this movement. Firstly, the announcement to amend the company's ...

Wide-moat West Pharmaceutical delivered solid fourth-quarter results, with full-year results in line with management’s previously stated guidance. Sales declined in the quarter by 3% ...